Literature DB >> 3753128

Transition from peristaltic esophageal contractions to diffuse esophageal spasm.

M Traube, R M Aaronson, R W McCallum.   

Abstract

A patient with dysphagia and chest pain was shown by manometry to have high-amplitude peristaltic esophageal contractions (nutcracker esophagus). Worsening symptoms over the next two years led to the performance of repeated manometric studies, which showed diffuse esophageal spasm. This demonstration of a transition from nutcracker esophagus to diffuse esophageal spasm lends further support for consideration of the nutcracker esophagus as a manometric disorder associated with chest pain or dysphagia. Furthermore, it suggests a pathophysiologic relationship between the nutcracker esophagus, a disorder with preserved peristalsis, and diffuse esophageal spasm, the classic dysmotility considered to be of neurogenic origin.

Entities:  

Mesh:

Year:  1986        PMID: 3753128

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Food impaction in nutcracker esophagus.

Authors:  R Breumelhof; H J Van Wijk; C D Van Es; A J Smout
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

2.  Manometric investigation of the entire esophagus in healthy subjects and patients with high-amplitude peristaltic contractions.

Authors:  G Bassotti; G Bacci; D Biagini; P David; G Alunni; M A Pelli; A Morelli
Journal:  Dysphagia       Date:  1988       Impact factor: 3.438

3.  Transition from nutcracker esophagus to achalasia.

Authors:  A Anggiansah; N F Bright; M McCullagh; W J Owen
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  Does diffuse esophageal spasm progress to achalasia? A prospective cohort study.

Authors:  Sayed Saeid Khatami; Farah Khandwala; Steven S Shay; Michael F Vaezi
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

Review 5.  Is Gastroesophageal Reflux Disease and Achalasia Coincident or Not?

Authors:  Da Hyun Jung; Hyojin Park
Journal:  J Neurogastroenterol Motil       Date:  2017-01-30       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.